A large-scale pandemic by human influenza virus H1N1 in 2009 caused severe health, social, and economic impacts. In this study, a photocatalyst technology based on TiO 2 , was evaluated for inactivation of a human influenza virus H1N1 isolated from a patient. The virus titer was reduced by 10 3.16 -fold within 24 h and more than 10 4.31 -fold inactivation within 48 h and 72 h. These results suggest that the tested photocatalyst technology based on TiO 2 can be used for reduction of influenza A virus adherence to other surfaces with Hizen-s inside diverse buildings, enabling effective control of its indirect contact infection. The photocatalyst is expected also to reduce level of the aerosol transmission of the virus.
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-fold within 24 h and more than 10 4.31 -fold inactivation within 48 h and 72 h. These results suggest that the tested photocatalyst technology based on TiO 2 can be used for reduction of influenza A virus adherence to other surfaces with Hizen-s inside diverse buildings, enabling effective control of its indirect contact infection. The photocatalyst is expected also to reduce level of the aerosol transmission of the virus. Hydroxyl radicals generated from photocatalyst reactions were considered to play a significant role in microbial inactivation (7) . Since photocatalytic properties of titanium dioxide (TiO 2 ) were first reported by Fujishima and Honda Two-hundred micro-liter of virus (1 × 10 6 pfu/ml) was spread on 100 mm cell culture dish containing culture medium of 2 ml and exposed to the TiO 2 generated by
Hizen-s for 24 h, 48 h, and 72 h. The viruses were collected from the cell culture dish depend on the exposure time. The collected viruses were quantified by plaque assay.
Inactivation levels were determined by Log reduction. All of the tests were performed by duplicate. Negative controls are performed without UV irradiation.
Negative control virus titer was constantly around 2.1 × 10 4 pfu/ml, whereas the virus titer on the photocatalyst based on TiO 2 was rapidly reduced after 24 h post-infection. 
